Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Philip Morris

It doesn't take a lot of money to begin investing. This stock costs around $100 a share and will pay you to hold it.

Have $100? This Stock Will Keep Paying You

Johnson & Johnson

PepsiCo

Procter & Gamble

UnitedHealth Group

Walgreens

Taking a look at defensive names, which ones look like solid buys at current prices? These seven, mostly in the consumer staple and healthcare sectors, may be some of the best opportunities right now among safe stocks.

7 Safe Stocks To Buy for an Increasingly Unstable World

Altria Group Inc. MO, +0.32% said Thursday its board of directors approved a 4.7% dividend increase to 90 cents a share. The quarterly dividend is payable on Oct. 12 to shareholders of record as of Sept.

Altria Group raises dividend by nearly 5%

RICHMOND, Va.--(BUSINESS WIRE)---- $MO--Altria Increases Quarterly Dividend by 4.7% to $0.90 Per Share

Altria Increases Quarterly Dividend by 4.7% to $0.90 Per Share

Shares of Altria have lagged the overall market over the past few months.

A Fresh Look At Altria

New York Community Bancorp

W. P. Carey

Exxon Mobil

Since the lows in March of 2020, the stock market has doubled. Think about that for a moment.

5 Buy-Rated Blue Chip Stocks Pay Reliable 5% or Higher Dividends

Recently Morgan Stanley noted that Philip Morris could achieve major benefits by acquiring Altria for $50 to $55 per share. Since the abandoned $200 billion merger in 2019, analysts have continued to believe such a deal made sense, and the current CEO of PM has left the door open for one.

4 Reasons Philip Morris Could Buy Altria In A $300 + Billion Mega-Merger

Dividend investors seeking to optimize income from their investments should look at ex-dividend dates and time their purchases accordingly. The question is, how?

Altria Is An Ex-Dividend Gift

Intuit

Lam Research

After years of a low interest rate environment, many investors have turned to equities not only for the growth potential but also for solid and dependable dividends that help to provide an income stream.

2 Sizzling Tech Stocks Highlight Buy-Rated Stocks With Rising Dividends

Altria Group﻿MO﻿ has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a staggering $10.45B worth of stock held by ETFs, and above-average ''DividendRank'' statistics including a strong 7.10% yield

Why Altria Group Is A Top 25 Dividend Giant

Verizon

If you're looking for high-yielding stocks with a history of hiking dividends, look no further!

2 Ultra-Yielding Dividend Giants Poised to Raise Dividends

British American Tobacco

Omega Healthcare Investors

Capital gains are nice for the future, but dividend-paying stocks provide income security for the present.I highlight 2 high dividend names that provide both income and capital gain potential.

I'm Doubling Down On These 2 Rich 8% Dividends

Altria's defensive characteristics were proven through the pandemic, with its earnings, dividend and total return performing resiliently. Historically, over the long term, MO's beta coefficient shows separation from macro-driven market moves, confirming its defensive nature.

Altria Is A Defensive Stronghold - Initiating At Strong Buy

AbbVie

Albemarle

Franklin Resources

Ecolab

Essex Property Trust

Federal Realty Investment Trust

ProShares S&P 500 Dividend Aristocrats ETF

AT&T

West Pharmaceutical Services

Dividend Aristocrats can be great investments, as they combine resilience, above-average yields, and income growth.

Dividend Aristocrats: 5 To Buy And 5 To Avoid

Apple

Anthem

Cisco Systems

Chevron

Home Depot

Lowe's

Microsoft

Pfizer

T. Rowe Price Group

Texas Instruments

Wells Fargo

Xcel Energy

This is a quarterly review of DivGro, my portfolio of dividend growth stocks. I write these reviews to summarize investment decisions and to share portfolio statistics. The article includes charts showing DivGro's composition and how positions contribute to projected annual dividend income.

Quarterly Review Of DivGro: Q2-2021

Enterprise Products Partners

Iron Mountain

Realty Income Corp

Cohen & Steers Quality Income Realty Fund

Saratoga Investment

Dividends are the focus of income investors. What exactly are they? Lots of confusion surround dividends as people approach them from the wrong perspective.

The Income Method: Understanding How Dividends Work

MedMen Enterprises Inc.

Tilray Brands

Candian cannabis giant Tilray, Inc. (NASDAQ: TLRY) announced Tuesday it has acquired the majority of the outstanding senior secured convertible notes of MedMen Enterprises Inc. (CSE:MMEN) (OTCQX: MMNFF) that were originally held by certain funds affiliated with Gotham Green Partners, LLC and other funds. The transaction is valued at $165.8 million.

Cantor Fitzgerald Says Tilray's Stake In MedMen One Of The Steps In The 'U.S.' Journey, Could Be Getting Close To Altria

Edison

Flowers Foods

Gaming and Leisure Properties

Huntington Bancshares

Kinder Morgan

M.D.C. Holdings

Medical Properties Trust

Merck

Newmont Mining

Sturm, Ruger & Company

Retail Opportunity Investments

Unum

Vale S.A.

Valero Energy

Williams

May-August, 2021, Kiplinger-Today listed eight-sets of stocks sorted as: best-buys for 2021, infrastructure-plays, value, growth, small-cap, high-yield, housing-bets, and cash-flow-gushers. Those eight "exceptional-dividend" articles revealed 86 equities. 76 pay-dividends. Kiplinger article-titles were, '21 Best Stocks to Buy'; '14 Best Infrastructure Stocks'; '16 Best Value; '10 Dividends-Growth'; '6 Small-Cap'; '10 High-Yield 4% or More;' '12 Housing; '10 Cash-Flow-Gushers.'

Kiplinger Exceptional August 2021 Dividends Features 13 Ideal Dogs

Agrify

Amplify Seymour Cannabis ETF

Alan Brochstein, a friend of the podcast and now a 3peat guest, is the founder of 420 Investor and New Cannabis Ventures. Thoughts on uplisting, the ETF MSOS, volume and valuation issues and confronting the California cannabis landscape.

Alan Brochstein: The Longer Legislation Takes, The Better For Cannabis Companies (Podcast Transcript)

News for Altria Stock (MO)